In vitro activity of telithromycin, a new ketolide, against Chlamydia pneumoniae

Journal of Antimicrobial Chemotherapy

Volumn 48, Issue 3, 2001, Pages 403-405

  Miyashita, N ^a   Fukano, H ^a   Niki, Y ^a   Matsushima, T ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; ERYTHROMYCIN; ERYTHROMYCIN DERIVATIVE; KETOLIDE; ROXITHROMYCIN; TELITHROMYCIN;

ANTIMICROBIAL ACTIVITY; ARTICLE; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; DRUG EFFICACY; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; RESPIRATORY TRACT INFECTION;

EID: 0034807046     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/48.3.403     Document Type: Article

References (10)

1. Antimicrobial activity of RU-6647, a new ketolide
2. In vitro activity of HMR 3647, a new ketolide antimicrobial agent
3. Chlamydia pneumoniae (TWAR)
4. In vitro and in vivo activities of AM-1155, a new fluoroquinolone, against Chlamydia spp
5. In vitro and in vivo activities of azithromycin, a new azalide antibiotic, against Chlamydia
6. In vitro activity of a new ketolide antibiotic, HMR 3647, against Chlamydia pneumoniae
7. In vitro activity of ABT 773, a new ketolide antibiotic, against Chlamydia pneumoniae
8. In vitro pharmacodynamics of the new ketolides HMR 3004 and HMR 3647 (telithromycin) against Chlamydia pneumoniae
9. Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: Comparative efficacy and safety of clarithromycin vs. erythromycin ethyl-succinate
10. Laboratory and clinical studies on roxithromycin in the treatment of chlamydial respiratory infections